Wolverine Asset Management’s Tevogen Inc Warrant TVGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Hold
200,638
﹤0.01% 1416
2026
Q1
$6.8K Hold
200,638
﹤0.01% 1458
2025
Q4
$8.47K Hold
200,638
﹤0.01% 1442
2025
Q3
$11.1K Hold
200,638
﹤0.01% 1357
2025
Q2
$14K Hold
200,638
﹤0.01% 1349
2025
Q1
$10.8K Hold
200,638
﹤0.01% 1302
2024
Q4
$10.8K Sell
200,638
-32,506
-14% -$1.78K ﹤0.01% 1351
2024
Q3
$3.01K Hold
233,144
﹤0.01% 1459
2024
Q2
$6.88K Sell
233,144
-4,424
-2% -$208 ﹤0.01% 1369
2024
Q1
$19.6K Sell
237,568
-20,462
-8% -$1.23K ﹤0.01% 1213
2023
Q4
$10.3K Hold
258,030
﹤0.01% 1377
2023
Q3
$12.9K Hold
258,030
﹤0.01% 1428
2023
Q2
$10.7K Hold
258,030
﹤0.01% 1379
2023
Q1
$20.6K Sell
258,030
-8,390
-3% -$464 ﹤0.01% 1342
2022
Q4
$2K Hold
266,420
﹤0.01% 1871
2022
Q3
$31K Hold
266,420
﹤0.01% 1719
2022
Q2
$42K Sell
266,420
-1,180
-0.4% -$278 ﹤0.01% 1615
2022
Q1
$72K Buy
+267,600
New +$99.5K ﹤0.01% 1405

Other funds holding TVGNW

Wolverine Asset Management's TVGNW Position: Q2 2026 in Review

Wolverine Asset Management held its Tevogen Inc Warrant (TVGNW) position steady in Q2 2026 at 200,638 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

Wolverine Asset Management first reported a position in TVGNW in Q1 2022 and has held it in 18 quarters since. The position peaked at $72K in Q1 2022. 33 funds tracked by Wall St. Rank hold TVGNW as of Q2 2026.

  • Wolverine Asset Management held 200,638 shares of Tevogen Inc Warrant worth $11.4K as of Q2 2026.
  • Wolverine Asset Management left its Tevogen Inc Warrant share count unchanged in Q2 2026.
  • Tevogen Inc Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1416 holding.
  • Wolverine Asset Management first reported a position in Tevogen Inc Warrant in Q1 2022 and has held it in 18 quarters since.
  • Wolverine Asset Management's Tevogen Inc Warrant position peaked at $72K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held Tevogen Inc Warrant as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.